Independent and cooperative action of Psen2 with Psen1 in zebrafish embryos

被引:42
|
作者
Nornes, Svonhild [1 ]
Newman, Morgan [1 ]
Wells, Simon [1 ]
Verdile, Giuseppe [2 ]
Martins, Ralph N. [2 ]
Lardelli, Michael [1 ]
机构
[1] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Genet, Adelaide, SA 5005, Australia
[2] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA 6027, Australia
基金
英国医学研究理事会;
关键词
Presenilin; Notch; gamma-secretase; Zebrafish; DoLA neurons; Melanocyte; ALZHEIMERS-DISEASE; NEURAL CREST; KUPFFERS VESICLE; GENE-EXPRESSION; GAMMA-SECRETASE; BETA-CATENIN; IN-VIVO; PRESENILIN-1; APOPTOSIS; DIFFERENTIATION;
D O I
10.1016/j.yexcr.2009.06.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Presenilin1 (PSEN1) and presenilin2 (PSEN2) are involved in the processing of type-l transmembrane proteins including the amyloid precursor protein (APP), Notch and several others. PSEN1 has been shown to be crucial for proteolytic cleavage of Notch in developing animal embryos. Mouse embryos lacking Psen1 function show disturbed neurogenesis and somite formation. resembling Notch pathway mutants. However, loss of Psen2 activity reveals only a minor phenotype. Zebrafish embryos are a valuable tool for analysis of the molecular genetic control of cell differentiation since endogenous gene expression call be modulated ill Subtle and complex ways to give a phenotypic readout. Using injection of morpholino antisense oligonucleotides to inhibit protein translation in zebrafish embryos, we show that reduced Psen2 activity decreases the number of melanocytes in the trunk but not in the Cranial area at 2 days post fertilisation (dpf). Reduced Psen2 activity apparently reduces Notch signalling resulting in perturbed spinal neurogenin1 (neurog1) expression, nenrogenesis and trunk and tail neural crest development. Similar effects are seen for reduced Psen1 activity. These results suggest that Psen2 plays a more prominent role in Notch signalling and embryo development in zebrafish than in mammals. Intriguingly, decreased Psen2 activity increases the number of Dorsal Longitudinal Ascending (DoLA) interneurons in the spinal cord while decreased Psen1 activity has no effect. However, the effect on Dol-As of reduced Psen2 can be ameliorated by Psen1 loss. The effects of changes in Psen2 activity on Dol-A interneurons and other cells in zebrafish embryos provide bioassays for more detailed dissection of Psen2 function. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:2791 / 2801
页数:11
相关论文
共 50 条
  • [21] Distinct Clinical Characteristics of PSEN1 P.Cys263phe Carriers Compared with Other PSEN1, PSEN2 and APP Carriers in a Flanders-Belgian AD Cohort
    Hens, Elisabeth
    Van den Ende, Jenneke
    Engelborghs, Sebastiaan
    Vandenberghe, Rik
    De Deyn, Peter
    Cras, Patrick
    Van Broeckhoven, Christine
    NEUROLOGY, 2021, 96 (15)
  • [22] Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations
    Pimenova, Anna A.
    Goate, Alison M.
    NEUROBIOLOGY OF DISEASE, 2020, 138
  • [23] Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer's disease
    Valdes, Phoebe
    Caldwell, Andrew B.
    Liu, Qing
    Fitzgerald, Michael Q.
    Ramachandran, Srinivasan
    Karch, Celeste M.
    Galasko, Douglas R.
    Yuan, Shauna H.
    Wagner, Steven L.
    Subramaniam, Shankar
    ALZHEIMERS RESEARCH & THERAPY, 2025, 17 (01)
  • [24] APP, PSEN1, and PSEN2 Variants in Alzheimer's Disease: Systematic Re-evaluation According to ACMG Guidelines
    Xiao, Xuewen
    Liu, Hui
    Liu, Xixi
    Zhang, Weiwei
    Zhang, Sizhe
    Jiao, Bin
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [25] Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy
    Li, Xu-Ying
    Cui, Yue
    Jing, Donglai
    Xie, Kexin
    Zhong, Xiaoling
    Kong, Yu
    Wang, Yuting
    Cha, Min
    Wang, Chaodong
    Wu, Liyong
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2021, 35 (03): : 208 - 213
  • [26] Spectrum of γ-Secretase dysfunction as a unifying predictor of ADAD age at onset across PSEN1, PSEN2 and APP causal genes
    Sara Gutiérrez Fernández
    Cristina Gan Oria
    Dieter Petit
    Wim Annaert
    John M. Ringman
    Nick C. Fox
    Natalie S. Ryan
    Lucía Chávez-Gutiérrez
    Molecular Neurodegeneration, 20 (1)
  • [27] The associations of APP, PSEN1, and PSEN2 genes with Alzheimer's disease: A large case-control study in Chinese population
    Xiao, Xuewen
    Liu, Hui
    Zhou, Lu
    Liu, Xixi
    Xu, Tianyan
    Zhu, Yuan
    Yang, Qijie
    Hao, Xiaoli
    Liu, Yingzi
    Zhang, Weiwei
    Zhou, Yafang
    Wang, Junling
    Li, Jinchen
    Jiao, Bin
    Shen, Lu
    Liao, Xinxin
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (01) : 122 - 128
  • [28] APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
    Lanoiselee, Helene-Marie
    Nicolas, Gael
    Wallon, David
    Rovelet-Lecrux, Anne
    Lacour, Morgane
    Rousseau, Stephane
    Richard, Anne -Claire
    Pasquier, Florence
    Rollin-Sillaire, Adeline
    Martinaudl, Olivier
    Quillard-Muraine, Muriel
    de la Sayette, Vincent
    Boutoleau-Bretonniere, Claire
    Etcharry-Bouyx, Frederique
    Chauvire, Valerie
    Sarazin, Marie
    le Berl, Isabelle
    Epelbaum, Stephane
    Jonveaux, Therese
    Rouaud, Olivier
    Ceccaldi, Mathieu
    Felician, Olivier
    Godefroy, Olivier
    Formaglio, Maite
    Croisile, Bernard
    Auriacombe, Sophie
    Chamard, Ludivine
    Vincent, Jean-Louis
    Sauvee, Mathilde
    Marelli-Tosi, Cecilia
    Gabelle, Audrey
    Ozsancak, Canan
    Pariente, Jeremie
    Paquet, Claire
    Hannequin, Didier
    Campion, Dominique
    PLOS MEDICINE, 2017, 14 (03)
  • [29] Identification and characterization of variants in PSEN1, PSEN2, and APP genes in Chinese patients with early-onset Alzheimer's disease
    Nan, Haitian
    Chu, Min
    Jiang, Deming
    Liang, Wenping
    Li, Yu
    Wu, Yiming
    Wang, Zhe
    Wu, Liyong
    ALZHEIMERS RESEARCH & THERAPY, 2025, 17 (01)
  • [30] Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
    Cruchaga, Carlos
    Chakraverty, Sumitra
    Mayo, Kevin
    Vallania, Francesco L. M.
    Mitra, Robi D.
    Faber, Kelley
    Williamson, Jennifer
    Bird, Tom
    Diaz-Arrastia, Ramon
    Foroud, Tatiana M.
    Boeve, Bradley F.
    Graff-Radford, Neill R.
    Jean, Pamela St.
    Lawson, Michael
    Ehm, Margaret G.
    Mayeux, Richard
    Goate, Alison M.
    PLOS ONE, 2012, 7 (02):